Industry News
-
J&J Transfers XLRP Gene Therapy Asset to MeiraGTx in Strategic Deal to Accelerate Global Approval
Apr 16 2026 -
Medera’s AAV-SERCA2a Gene Therapy Secures FDA Fast Track for Duchenne Cardiomyopathy
Apr 16 2026 -
Roche Launches New Global Phase III Trial to Address EMA Concerns in DMD
Apr 16 2026 -
MeiraGTx Reports Durable 3-Year Efficacy and Safety Data for AAV-hAQP1 in Radiation-Induced Xerostomia
Apr 16 2026 -
Meta-analysis suggests gene therapy may reduce treatment burden in neovascular AMD
Apr 14 2026 -
Affinia Therapeutics Secures Health Canada CTA Approval for AAV Gene Therapy AFTX-201 in BAG3 Cardiomyopathy
Apr 14 2026 -
FDA Issues Draft Guidance on Genome Editing Safety Standards to Assess Safety and Off-Target Editing Risks
Apr 14 2026 -
Grace Science Secures RMAT Designation for AAV9 Gene Therapy GS-100 in NGLY1 Deficiency
Apr 14 2026 -
AvenCell Doses First Patient with CRISPR-Engineered Allogeneic Dual-Target CAR-T Therapy AVC-203
Apr 13 2026